| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
4,090 |
4,068 |
$446K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
7,540 |
1,526 |
$153K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,458 |
2,748 |
$120K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,581 |
3,487 |
$116K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,707 |
1,581 |
$48K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,629 |
2,135 |
$48K |
| 99233 |
Prolong inpt eval add15 m |
832 |
436 |
$25K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
809 |
551 |
$15K |
| 99223 |
Prolong inpt eval add15 m |
287 |
282 |
$12K |
| 90961 |
|
127 |
127 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
141 |
138 |
$8K |
| 99205 |
Prolong outpt/office vis |
58 |
58 |
$3K |
| 99215 |
Prolong outpt/office vis |
54 |
51 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
72 |
58 |
$2K |
| 99000 |
|
553 |
402 |
$1K |